BI
Biovie Inc
🇺🇸XNAS.BIVIUnited StatesHealthcare
$1.78USDdown -0.27 (-13.17%)OpenEnd of day5:11 PM
Price$1.78-0.27 (-13.17%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US09074F5044
- CUSIP
- 09074F207
Company
- Employees
- 13
- Headquarters
- Carson City, United States
- Website
- https://bioviepharma.com
- CEO
- Mr. Cuong Viet Do M.B.A.
Market
- Shares outstanding
- 8.5M
- Market cap
- $15.04M
Key dates
- Next earnings
- Nov 9, 2026
Highlights
- Market cap
- $15.04M
- EPS LTM
- -$2.61calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -0.68calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $00%unchanged year on year
- Net income
- -$22.07M-25.83%down year on year
- Gross margin
- Not reported
- Free cash flow
- -$19.02M0%unchanged year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.